AI and the Pharmaceutical Industry — Weekly 2026-W39
This page is a mechanical aggregation of the daily data and carries no commentary. See the daily pages for interpretation.
💰 Investment MapAmounts are extracted from source text by pattern matching only. No currency conversion.
🧬 Drug Discovery5
- S2 Deal / PartnershipAbbVie Forms Ai-Powered Drug Discovery Partnership with Lambic | PharmExec — Pharmaceutical Executive09/22 03:57 JSTAbbVie
- S2 Deal / PartnershipAbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery — Yahoo! Finance Canada09/21 21:00 JSTAbbVieAlso reported by 1: AD HOC NEWS
- S2 Deal / PartnershipThe Cat Health Company Partners With Ad Atomica on AI-Led De Novo Drug Discovery — einnews.com09/21 20:30 JST
- S3 Capital moveNvidia-Backed AI Drug Discovery Company Iambic Therapeutics Files for Nasdaq IPO, to Use Proceeds for Cancer Drug Development — Yahoo Finance09/22 11:00 JSTIambic TherapeuticsAlso reported by 5: marketscreener.com · finance.biggo.com · medwatch.com · konsulteer.com · Bloomberg.com
- S3 Capital moveNVIDIA-backed AI drug discovery company Iambic Therapeutics applies for Nasdaq listing — BigGo ファイナンス09/23 03:06 JST
🧪 Clinical Development0
No items today · See past 90 days →
📑 CTD / Regulatory Submission0
No items today · See past 90 days →
🩺 GCP Operations0
No items today · See past 90 days →
📘 ICH Guidelines & AI0
No items today · See past 90 days →
🛡️ Pharmacovigilance / GVP0
No items today · See past 90 days →
📊 RWE / Evidence Generation0
No items today · See past 90 days →
🎓 Medical Affairs0
No items today · See past 90 days →
💼 Sales0
No items today · See past 90 days →
📣 Marketing0
No items today · See past 90 days →
🚚 Distribution / Supply Chain0
No items today · See past 90 days →
✅ GQP / Quality Assurance0
No items today · See past 90 days →
👥 Human Resources0
No items today · See past 90 days →
💴 Finance & Accounting0
No items today · See past 90 days →
🏛️ Enterprise AI Platform & Governance8
- S4 Amount disclosedByteDance spin-off Anew Labs raises US$290m as AI drug developers enjoy fundraising boomUS$290m — The Star09/20 20:00 JST
- S4 Amount disclosedWhat Is Tempus AI (TEM)? The $98.5M Mark Behind Q2$98.5M — Phemex09/20 13:49 JSTTempus AI
- S4 Amount disclosedMithrl Raises $20M to Scale Its Biopharma AI Infrastructure$20M — Wowtale09/20 08:03 JST
- S4 Amount disclosedAnthropic's $400M Buy Gives New York's Life Sciences' AI Sector a Boost$400M — Globest09/21 21:10 JSTAnthropic
- S2 Deal / PartnershipAbbVie partners with Iambic to apply AI platform across immunology, neuroscience, and oncology — AllSci09/22 00:01 JSTAbbVie
- S2 Deal / PartnershipInsilico Medicine Cayman Topco Enters AI Co-Development Collaboration — TradingView09/21 19:19 JSTInsilico MedicineAlso reported by 1: marketscreener.com
- S4 Amount disclosedBoehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenicsup to $1B — biospace.com09/22 22:13 JSTBoehringer Ingelheim
- S3 Capital moveTempus AI raises full-year outlook after 22% re... — Pluang09/22 20:28 JSTTempus AI